P681: MATCHING-ADJUSTED INDIRECT COMPARISON OF ASCIMINIB VERSUS OTHER TYROSINE KINASE INHIBITORS IN THIRD-OR-LATER LINE CHRONIC-PHASE CHRONIC MYELOID LEUKEMIA
Ehab Atallah,
Aurore Yocolly,
Kejal Jadhav,
Teresa Kangappaden,
Andrea Damon,
Imtiaz A. Samjoo,
Devarshi Bhattacharyya
Affiliations
Ehab Atallah
1 Medical College of Wisconsin, Milwaukee, United States
Aurore Yocolly
2 Novartis Services Inc., East Hanover, United States
Kejal Jadhav
3 Novartis Pharmaceuticals Corporation, East Hanover, United States
Teresa Kangappaden
4 EVERSANA, Burlington, Canada
Andrea Damon
3 Novartis Pharmaceuticals Corporation, East Hanover, United States
